Investor insights
Sectors invested in
Funding rounds participated in
$75M sweet spot round size
Most of their 15 investments are in rounds between $52M and $105M
Investor type
Basic info
Industry
Sectors
Date founded
2017
Investments made
Alentis Therapeutics raised $105M on April 13, 2023
Investors: Pureos Bioventures, Schroders Capital, Novo Holdings, RA Capital Management, L.P. and JEITO
Noema Pharma raised $110M on March 7, 2023
Investors: UPMC Enterprises, Polaris Partners, Sofinnova Partners, The Invus Group, Gilde Healthcare, Forbion and JEITO
PULMOCIDE LIMITED raised $52M on December 6, 2022
Investors: 旭化成ファーマ（株）, Vivo Capital, F-Prime Capital Partners, S.R. One Ltd, Longwood Fund, IP Group plc, SV Life Sciences and JEITO
CatalYm GmbH raised $51M on November 22, 2022
Investors: Brandon Capital Partners, coparion, Vesalius Biocapital, BGV (BioGeneration Ventures), Forbion, Bayern Kapital GmbH and JEITO
HIBio raised $120M on November 1, 2022
Investors: Monograph Capital, ARCH Venture Partners and JEITO
SparingVision raised $75M on September 14, 2022
Investors: RD Fund, UPMC Enterprises, Ysios Capital and JEITO
CDR-Life Inc. raised $76M on April 13, 2022
Investors: Omega Funds, RA Capital Management, L.P. and JEITO
EyeBio raised $65M on February 22, 2022
Investors: Samsara BioCapital and JEITO
NMD Pharma raised $40M on February 15, 2022
Investors: Novo Holdings, Inkef and JEITO
Quell Therapeutics raised $156M on November 29, 2021
Investors: SV Life Sciences, Tekla Capital Management, Syncona Limited, Monashee Investment Management LLC, British Patient Capital, Ridgeback Capital Management LLC, Point72 Asset Management and JEITO